Anbio Biotechnology Investing Cash Flow
Anbio Biotechnology (NNNN) reported Investing Cash Flow of -$4.20 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-04-07
| Period end | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|
| 2025-12-31 | -$4.20M 20-F · filed 2026-04-07 |
| 2024-12-31 | $337.10K 20-F · filed 2026-04-07 |
| 2023-12-31 | $1.73M 20-F · filed 2026-04-07 |
| 2022-12-31 | -$1.53M 20-F · filed 2025-04-28 |